Abstract
We sought to determine whether HBOT leads to parental reported behavioral changes and alterations in cytokines in children with ASD. Ten children completed 80 sessions of HBOT and all improved by 2 points on the clinician-rated CGI-I scale (much improved) as well as several parent-completed measures of behavior. The lack of a control group limits the ability to determine if improvements were related to HBOT. Enrolled children did not exhibit abnormal cytokine levels at baseline and no significant changes in mean cytokine levels were observed. Although this study was limited by the small sample size and by the variable nature of cytokines, we found no evidence that HBOT affects cytokine levels or that cytokine levels were associated with behavioral changes.
References
Ashwood, P., & Van de Water, J. (2004). A review of autism and the immune response. Clinical & Developmental Immunology, 11(2), 165–174.
Bennett, M. H., Kertesz, T., & Yeung, P. (2007). Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database of Systematic Reviews, 1, CD004739.
Collet, J. P., Vanasse, M., Marois, P., Amar, M., Goldberg, J., Lambert, J., et al. (2001). Hyperbaric oxygen for children with cerebral palsy: A randomised multicentre trial. HBO-CP research group. Lancet, 357(9256), 582–586.
Gill, A. L., & Bell, C. N. (2004). Hyperbaric oxygen: Its uses, mechanisms of action and outcomes. QJM, 97(7), 385–395.
Granpeesheh, D., Tarbox, J., Dixon, D. R., Wilke, A. E., Allen, M. S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 268–275.
Jepson, B., Granpeesheh, D., Tarbox, J., Olive, M. L., Stott, C., Braud, S., et al. (2010). Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. Journal of Autism and Development Disorders, 415(5), 575–588.
Kranke, P., Bennett, M., Roeckl-Wiedmann, I., & Debus, S. (2004). Hyperbaric oxygen therapy for chronic wounds. Cochrane Database of Systematic Reviews, 2, CD004123.
Leach, R. M., Rees, P. J., & Wilmshurst, P. (1998). Hyperbaric oxygen therapy. BMJ, 317(7166), 1140–1143.
Lin, H. C., Wan, F. J., Wu, C. C., Tung, C. S., & Wu, T. H. (2005). Hyperbaric oxygen protects against lipopolysaccharide-stimulated oxidative stress and mortality in rats. European Journal of Pharmacology, 508(1–3), 249–254.
McDonagh, M., Carson, S., Ash, J., Russman, B. S., Stavri, P. Z., Krages, K. P., et al. (2003). Hyperbaric oxygen therapy for brain injury, cerebral palsy, and stroke. Evidence Report/Technology Assessment (Summary), 85, 1–6.
McDonagh, M., Helfand, M., Carson, S., & Russman, B. S. (2004). Hyperbaric oxygen therapy for traumatic brain injury: A systematic review of the evidence. Archives of Physical Medicine and Rehabilitation, 85(7), 1198–1204.
Rossignol, D. A., & Rossignol, L. W. (2006). Hyperbaric oxygen therapy may improve symptoms in autistic children. Medical Hypotheses, 67(2), 216–228.
Rossignol, D. A., Rossignol, L. W., James, S. J., Melnyk, S., & Mumper, E. (2007). The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: An open-label pilot study. BMC Pediatrics, 7, 36.
Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics, 9, 21.
Senechal, C., Larivee, S., Richard, E., & Marois, P. (2007). Hyperbaric oxygenation therapy in the treatment of cerebral palsy: A review and comparison to currently accepted therapies. Journal of American Physicians and Surgeons, 12(4), 109–113.
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57(1), 67–81.
Yasar, M., Yildiz, S., Mas, R., Dundar, K., Yildirim, A., Korkmaz, A., et al. (2003). The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiological Research, 52(1), 111–116.
Acknowledgments
We gratefully acknowledge the families and children who participated in this study to help advance scientific research in autism. This work was supported by grants from the MIND Institute (Dr. Hendren) and Autism Speaks, the Higgins Family Foundation, The Emch Foundation, The Taube Foundation, NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131 (Dr. Bent) and the C.H.E.R.I.S.H. Foundation (Edward Nemeth), which provided funding for all HBOT treatments.
Author information
Authors and Affiliations
Corresponding author
Additional information
Clinical Trial Registry: Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism (HBOT); NCT00584480; http://www.clinicaltrials.gov/ct2/show/NCT00584480.
Rights and permissions
About this article
Cite this article
Bent, S., Bertoglio, K., Ashwood, P. et al. Brief Report: Hyperbaric Oxygen Therapy (HBOT) in Children with Autism Spectrum Disorder: A Clinical Trial. J Autism Dev Disord 42, 1127–1132 (2012). https://doi.org/10.1007/s10803-011-1337-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-011-1337-3